![[Rishi Pimentel, gChem]](https://cdn.sanity.io/images/0vv8moc6/pharmtech/16bc98940a34f0991f9ca5e7ccbfa6889fec078f-1634x909.jpg?w=350&fit=crop&auto=format)
Blog|Videos|January 9, 2024
Importance of a Hybrid Approach to Manufacturing and Sourcing
Author(s)Actylis
Bradley Grobler, Vice President of Sales, Pharma & Biopharma Europe, describes how Actylis meets global demands for (bio)pharmaceutical development and manufacturing programs during CPhI 2023.
Learn more:
- A unique hybrid model of global manufacturing and sourcing
- R&D services and custom manufacturing for pharmaceutical and biopharmaceutical companies combining the collective expertise of more than 75 years
- Flexible manufacturing capacity and scalability offered by combining in-house capabilities and toll partners’ scale
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
![[Rishi Pimentel, gChem]](https://cdn.sanity.io/images/0vv8moc6/pharmtech/01d391920288b8bd8b751988988b5a6544a6ddaa-1629x908.jpg?w=350&fit=crop&auto=format)
![[Nigel Langley]](https://cdn.sanity.io/images/0vv8moc6/pharmtech/e2c0137d8224aaa1f14c0f1af43b58d21f4541dd-1768x904.jpg?w=350&fit=crop&auto=format)
Trending on Pharmaceutical Technology
1
New Targets for Clinical Trials in the European Union
2
Shifting from Trial-and-Error to Rational Design Drives Efficiency in Pharmaceutical Formulation
3
Nuclear Waste to Medicine: The UK’s Lead-212 Strategy for Cancer Care
4
Leveraging AI/ML to Reduce Risk in Drug Development: Part One
5
